Evidence-led education. Independently researched. Medically reviewed content clearly labeled.
Live Wellness

GLP-1 fundamentals

How GLP-1 Medications Work

A plain-language guide to appetite, digestion, blood sugar and the differences among incretin medications.

Updated July 28, 2026 9 min read

GLP-1 medicines mimic or amplify hormone signals involved in appetite, digestion and glucose regulation. Different drugs target different receptors and carry different approved uses.

What to know

  • They can reduce appetite and slow stomach emptying.
  • They are tools—not replacements for nutrition, movement and medical follow-up.
  • Benefits and risks depend on the medication and the person.

The hormone signal

GLP-1 is an incretin hormone released after eating. It helps the pancreas release insulin when glucose is elevated, reduces glucagon and sends fullness signals. Medicines designed around this pathway last longer than native GLP-1.

Why appetite may change

Many people report earlier fullness and less food noise. The effect is not identical for everyone, and pushing food intake too low can make it harder to meet protein, fiber and micronutrient needs.

What the medicine cannot do alone

Medication does not automatically preserve muscle, improve cardiorespiratory fitness or build sustainable routines. Resistance training, adequate protein, sleep and follow-up remain important parts of care.

Single- and dual-receptor medicines

Semaglutide-based medicines act at the GLP-1 receptor. Tirzepatide acts at both GIP and GLP-1 receptors. That difference helps explain why brand names are not interchangeable even when they are discussed together as incretin-based medicines.

Approved use comes before the nickname

A diabetes medicine and a chronic weight-management medicine may contain the same active ingredient but have different labels, doses, and eligibility criteria. Use the specific product label—not a social-media category—to understand what a prescription is approved to treat.

Questions to bring to an appointment

Ask which diagnosis the prescription is intended to treat, how the dose will be increased, which side effects should prompt a call, and how other medicines affect the plan. Also discuss what follow-up will measure beyond body weight, such as symptoms, glucose, nutrition, or function when relevant.

Frequently asked questions

Are all GLP-1 medications the same?

No. Active ingredients, receptor targets, doses, delivery forms and FDA-approved indications differ.

Do GLP-1s permanently change metabolism?

They influence appetite and metabolic regulation while used. Weight regain after stopping is common in trials, so any discontinuation plan should be discussed with a clinician.

Sources

  1. Ozempic prescribing information — U.S. Food and Drug Administration (2026-05)
  2. Wegovy prescribing information — U.S. Food and Drug Administration (2025-12)
  3. Mounjaro prescribing information — U.S. Food and Drug Administration (2026)
  4. Zepbound prescribing information — U.S. Food and Drug Administration (2026-02)

Continue learning